BioPharm International, August 2021 Issue

FDA Inspections Back on Track?

August 01, 2021

From the Editor

34

8

Congress questions FDA on plans to catch up and move forward with facility inspections as pandemic travel restrictions ease.

GMPs for Emerging Therapies

August 01, 2021

Ask The Expert

34

8

Experts Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Steven J. Lynn, executive vice-president, Pharmaceuticals for Regulatory Compliance Associates, provide answers to frequently asked regulatory questions about advanced therapy medicinal products.